BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 8656904)

  • 1. Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies.
    Collaborative Group on Hormonal Factors in Breast Cancer
    Lancet; 1996 Jun; 347(9017):1713-27. PubMed ID: 8656904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.
    Contraception; 1996 Sep; 54(3 Suppl):1S-106S. PubMed ID: 8899264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 1997 Oct; 350(9084):1047-59. PubMed ID: 10213546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptives and breast cancer risk among younger women.
    Brinton LA; Daling JR; Liff JM; Schoenberg JB; Malone KE; Stanford JL; Coates RJ; Gammon MD; Hanson L; Hoover RN
    J Natl Cancer Inst; 1995 Jun; 87(11):827-35. PubMed ID: 7791232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer risk: perception versus reality.
    Westhoff CL
    Contraception; 1999 Jan; 59(1 Suppl):25S-28S. PubMed ID: 10342093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptives and breast cancer.
    Brinton LA; Hoover R; Szklo M; Fraumeni JF
    Int J Epidemiol; 1982 Dec; 11(4):316-22. PubMed ID: 7152784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: prospective, nationwide cohort study.
    Iversen L; Fielding S; Lidegaard Ø; Mørch LS; Skovlund CW; Hannaford PC
    BMJ; 2018 Sep; 362():k3609. PubMed ID: 30257920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis.
    Fitzpatrick D; Pirie K; Reeves G; Green J; Beral V
    PLoS Med; 2023 Mar; 20(3):e1004188. PubMed ID: 36943819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives as related to cancer and benign lesions of the breast.
    Fasal E; Paffenbarger RS
    J Natl Cancer Inst; 1975 Oct; 55(4):767-73. PubMed ID: 1185801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives and risk of breast cancer.
    Paul C; Skegg DC; Spears GF
    Int J Cancer; 1990 Sep; 46(3):366-73. PubMed ID: 2394503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary Hormonal Contraception and the Risk of Breast Cancer.
    Mørch LS; Skovlund CW; Hannaford PC; Iversen L; Fielding S; Lidegaard Ø
    N Engl J Med; 2017 Dec; 377(23):2228-2239. PubMed ID: 29211679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraceptives and breast cancer: review of the epidemiologic literature.
    Thomas DB
    Contraception; 1991 Jun; 43(6):597-642. PubMed ID: 1868735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exogenous progestins and breast cancer.
    Stanford JL; Thomas DB
    Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lifetime cancer risk and combined oral contraceptives: the Royal College of General Practitioners' Oral Contraception Study.
    Iversen L; Sivasubramaniam S; Lee AJ; Fielding S; Hannaford PC
    Am J Obstet Gynecol; 2017 Jun; 216(6):580.e1-580.e9. PubMed ID: 28188769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of thyroid cancer in women in relation to reproductive and hormonal factors.
    McTiernan AM; Weiss NS; Daling JR
    Am J Epidemiol; 1984 Sep; 120(3):423-35. PubMed ID: 6475918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weighing the evidence on the pill and breast cancer.
    Johnson JH
    Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality among oral contraceptive users: 20 year follow up of women in a cohort study.
    Vessey MP; Villard-Mackintosh L; McPherson K; Yeates D
    BMJ; 1989 Dec; 299(6714):1487-91. PubMed ID: 2514858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. At pill's 30th birthday, breast cancer question is unresolved.
    Althaus FA; Kaeser L
    Fam Plann Perspect; 1990; 22(4):173-6. PubMed ID: 2226748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.